• SENSEX 76,445.12
    420.61 (+0.55%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    700.65 1,576.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Bharat Electron
    274.50 204.00(%)
  • Vodafone Idea
    8.33 19.15(%)
  • SRF
    2,939.00 3,074.95(%)
  • SpiceJet
    46.10 79.90(%)
  • Mazagon Dock
    2,601.00 2,929.98(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • M & M
    2,660.50 3,276.30(%)
  • Emcure Pharma
    1,095.80 1,577.50(%)
  • Kalyan Jewellers
    495.00 794.60(%)
  • Hind.Aeronautics
    4,151.55 3,045.95(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Tata Consumer
    1,073.55 1,247.39(%)
  • Adani Green
    939.70 2,173.65(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Birlasoft Ltd
    393.85 791.95(%)
  • Quadrant Future
    583.50 743.45(%)
  • Zerodha Nifty 1D
    107.86 108.00(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ERIS Lifesciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 66197.0
  • ISIN : INE406M01024
1,390.00 -27 (-1.93%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1,370.00

  • Today’s High

    1,406.95

  • Open

    1,400.00

  • Perv Close

    1,417.35

  • 52W Low

    815.85

  • 52W High

    1,593.90

Key Indicators

  • P/E(TTM)

    219.04

  • Mar.Cap (₹Cr.)

    18,926.60

  • Div & Yield %

    0.00

  • Book Value(₹)

    189.25

  • Debt-Equity Ratio

    -1.93

  • AGM Date

    01-Apr-2025

  • EPS

    6.35

  • P/E Ratio

    219.04

Financials Ratios

  • Debt-Equity Ratio

    0.76

  • Mar.Cap (₹Cr.)

    18,926.60

  • RONW (%)

    16.61

  • ROCE (%)

    12.05

Score Board

  • Equity (₹ in Cr.)

    13.62

  • BV (₹)

    189.20

  • Sales( ₹ in Cr.)

    1,528.28

  • NP (in Cr.)

    296.92

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    29.30

  • EPS (₹)

    21.80

  • Traded Value (₹ in Lakhs)

    18,938.85

  • 52 Week High

    1,593.90

  • 52 Week Low

    815.85

  • Price BSE

    1391.0

  • Price NSE

    1,390.00

  • Market Capital( in Cr.)

    18,938.85

  • P/C Ratio

    47.40

  • P/E Ratio

    63.80

  • Price Vs.BV

    21.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,486.71 1,330.73 1,215.73 1,108.83 1,020.23 896.54
Excise Duty 1,454.75 1,307.12 1,193.77 1,088.65 1,003.76 881.13
Net Sales 1,486.71 1,330.73 1,215.73 1,108.83 1,020.23 896.54
Other Income 34.83 17.26 28.99 10.00 14.73 32.50
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,521.53 1,347.99 1,244.72 1,118.83 1,034.96 929.04
EXPENDITURE :
Raw Materials 1,454.75 1,307.12 1,193.77 1,088.65 1,003.76 881.13
Power & Fuel Cost 1,454.75 1,307.12 1,193.77 1,088.65 1,003.76 881.13
Employee Cost 331.67 252.52 220.11 207.02 191.73 166.77
Other Manufacturing Expenses 122.13 87.78 84.99 93.28 74.04 4.20
Selling & Administrative Expenses 277.68 233.02 215.51 181.66 219.34 251.38
Miscellaneous Expenses 122.13 87.78 84.99 93.28 74.04 4.20
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,192.70 911.08 786.18 729.94 711.37 617.26
Operating Profit 21.25 15.91 11.48 11.05 15.17 8.19
Interest 57.42 20.81 2.99 0.78 1.85 22.79
Gross Profit 328.83 436.91 458.54 388.89 323.59 311.78
Depreciation 102.39 64.66 51.46 37.64 44.88 31.59
Profit Before Tax 328.83 436.91 458.54 388.89 323.59 311.78
Tax 57.64 76.50 80.17 70.18 57.49 68.87
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -28.52 -37.59 -38.83 -31.90 -25.17 -42.47
Reported Net Profit 299.71 398.01 417.19 350.61 291.27 285.38
Extraordinary Items 328.83 436.91 458.54 388.89 323.59 311.78
Adjusted Net Profit 299.71 398.01 417.19 350.61 291.27 285.38
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 99.95 81.65 74.68 38.97 0.00
P & L Balance carried down 299.71 398.01 417.19 350.61 291.27 285.38
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 735.00 601.00 550.00 287.00 0.00
Dividend Per Share(Rs) 0.00 7.35 6.01 5.50 2.87 0.00
Earnings Per Share-Unit Curr 22.04 29.27 30.70 25.82 21.23 20.75
Book Value 0.00 99.95 81.65 74.68 38.97 0.00
Book Value(Adj)-Unit Curr 0.00 99.95 81.65 74.68 38.97 0.00

Shareholding Pattern

  • Promoter Group

    54.86%

  • Public Share Holding

    45.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74,683,744 54.86 74,683,744 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 74,683,744 54.86 74,683,744 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10 0.00 10 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3 0.00 3 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,369,613 8.35 11,369,613 134
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,009,293 0.74 1,009,293 3
Mutual Funds / UTI 22,483,264 16.52 22,483,264 20
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,098,032 0.81 1,098,032 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 35,960,215 26.42 35,960,215 172
2] Non Institution
Bodies Corporate 512,477 0.38 512,477 276
Clearing Members 149 0.00 149 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 238,445 0.18 238,445 1,138
Foreign Non Institution Other 11,965,882 8.79 11,965,882 1
Hindu Undivided Families 82,623 0.06 82,623 990
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,033,474 6.64 9,033,474 6
Individuals holding nominal share capital up to Rs. 1 lakh 3,610,568 2.65 3,610,568 50,690
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,543 0.00 2,543 1
Others 0 0.00 0 0
Sub Total 25,485,323 18.72 25,485,323 53,137
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 136,129,282 100.00 136,129,282 53,314

Company Background

ERIS Lifesciences LtdPharmaceuticals - Indian - Formulations

  • ERIS Lifesciences Ltd
  • BSE Code : 66197.0
  • ISIN : INE406M01024

  • Incorporation Year

    2007

  • Registered Office

    8th Floor Commerce House -IV
    Prahladnagar 100 FT Road, Ahmedabad,
    Gujarat-380015

  • Telephone

    91-79-30451000

  • FAX

    91-79-48903474

  • Chairman

    Amit Indubhushan Bakshi

  • Managing Director

    Amit Indubhushan Bakshi

  • Company Secretary

    Milind Talegaonkar

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

ERIS Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ERIS Lifescience 1,390.90 1,521.53 1,486.71 219.04 9.98
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92